Press release
Diabetic Retinopathy Market 2025 | Industry Developments, Future Growth, Share & Industry Insights | Novartis International AG, Glycadia Pharmaceuticals, Regeneron Pharmaceuticals Inc and Valeant Pharmaceutical, Allergan plc, Ampio Pharmaceuticals
Diabetic Retinopathy
DataM Intelligence has published a new research report on "Diabetic Retinopathy Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
According to the IDF Diabetes Atlas (10th Edition), about 51 million adults (14.6%) in the IDF NAC region were living with diabetes in 2021, with 193,000 children and adolescents affected by type 1 diabetes. In June 2022, Regeneron announced that the U.S. FDA accepted its EYLEA (aflibercept) sBLA for a 16-week dosing regimen in diabetic retinopathy, with a decision expected by February 2023.
Get a Free Detail Sample Research PDF - https://datamintelligence.com/download-sample/diabetic-retinopathy-market?kb
The Diabetic Retinopathy market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.
Regulatory and FDA Approvals (2025)
The FDA approved Genentech's Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic retinopathy in May 2025. Susvimo offers continuous drug delivery with just one refill every nine months, reducing treatment burden.
Several aflibercept biosimilars were approved in 2024, increasing accessibility and creating price competition for DR therapies.
FDA has also extended review periods for Regeneron's Eylea HD submissions targeting enhanced indications and extended dosing intervals for DR and related diseases.
AI-based autonomous diagnostic systems for diabetic retinopathy screening, such as IDX-DR, have received FDA approval, enabling wider, earlier detection and intervention.
Forecast Growth Projected:
The Global Diabetic Retinopathy Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
List of the Key Players in the Diabetic Retinopathy Market:
Abbott Laboratories, Alimera Science, Allergan plc, Ampio Pharmaceuticals, Bayer AG, Hoffmann-La Roche, Novartis International AG, Glycadia Pharmaceuticals, Regeneron Pharmaceuticals Inc and Valeant Pharmaceutical.
Segment Covered in the Diabetic Retinopathy Market:
By Indication Type: (Non-Proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy)
By Treatment Type: (Anti-Vascular Endothelial Growth Factor (VEGF) drug, Intraocular Steroid Injection, Laser Surgery, Vitrectomy)
By End User: (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers)
Latest Market News and Innovations
Partnerships are improving AI-driven risk stratification and personalized screening intervals for DR to reduce unnecessary exams and lower healthcare costs, illustrated by Remidio and RetinaRisk collaboration in 2025.
Gene therapy trials like RGX-314 anticipate potentially transformative one-time treatments for diabetic retinopathy, currently in late-stage Phase 3 trials.
Global growth drivers include increasing diabetes prevalence, rising awareness, better screening programs, and innovative treatment options reducing vision loss risk globally.
Get Customization in the report as per your requierments: https://datamintelligence.com/customize/diabetic-retinopathy-market?kb
Regional Analysis:
The global Diabetic Retinopathy Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Diabetic Retinopathy Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Diabetic Retinopathy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Diabetic Retinopathy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @ https://www.datamintelligence.com/buy-now-page?report=diabetic-retinopathy-market?kb
People Also Ask
How large is the Diabetic Retinopathy Market?
The Diabetic Retinopathy Market size was valued at US$ 7,167.00 million in 2023 and is projected to grow to US$ 11,702.89 million by 2031
How quickly is the Diabetic Retinopathy Market expanding?
The Diabetic Retinopathy Market is forecasted to grow at a CAGR of 6.4% between 2024 and 2031, showing strong growth momentum
Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/diabetic-retinopathy-market?kb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Retinopathy Market 2025 | Industry Developments, Future Growth, Share & Industry Insights | Novartis International AG, Glycadia Pharmaceuticals, Regeneron Pharmaceuticals Inc and Valeant Pharmaceutical, Allergan plc, Ampio Pharmaceuticals here
News-ID: 4250815 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Polymerase Chain Reaction (PCR) Market Rapid Growt 2025-2033: Most Leading Compa …
polymerase chain reaction market size reached US$ 11.58 Billion in 2023 with a rise of US$ 12.33 Billion in 2024 and is expected to reach US$ 22.66 Billion by 2033, growing at a CAGR of 7.0% during the forecast period 2025-2033.
Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/polymerase-chain-reaction-market?kb
United States: Recent Industry Developments
✅ November 2025: Thermo Fisher Scientific launched an ultra-fast PCR system…
Transformer Monitoring Systems Industry Trends Shaping Energy Sector | Most Lead …
DataM Intelligence has published a new research report on "Transformer Monitoring Systems Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Sample PDF Of This Report…
Future of Performance Elastomers Market Through 2032: Most Leading Companies - Z …
DataM Intelligence has published a new research report on "Performance Elastomer Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Sample PDF Of This Report (Get…
Wireless Charging Market to Reach US$ 60.7 Billion by 2031 | Strong 27.3% CAGR | …
The Global Wireless Charging Market was valued at US$ 8.9 billion in 2023 and is projected to reach US$ 60.7 billion by 2031, growing at a CAGR of 27.3% during the forecast period 2024-2031. The market is experiencing strong momentum driven by the rapid adoption of smartphones, wearables, electric vehicles, and smart home devices, all of which increasingly rely on convenient, cable-free power solutions. Expanding consumer preference for seamless charging…
More Releases for Diabetic
Exploring The Diabetic Retinopathy Market In A Diabetic-Prevalent World: The Dri …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Diabetic Retinopathy Market Size Growth Forecast: What to Expect by 2025?
The diabetic retinopathy market has experienced robust expansion over the last few years, with projections indicating a rise from $8.61 billion in 2024 next year to $9.26 billion in 2025, reflecting a compound annual growth rate (CAGR) of…
Diabetic Socks Market Dynamics Shaped by Rising Diabetic Population - Persistenc …
The diabetic socks market is gaining significant traction worldwide, driven by the rising prevalence of diabetes and related complications such as diabetic neuropathy and foot ulcers. Designed specifically to cater to the needs of diabetic patients, these socks play a crucial role in foot protection by preventing blistering, reducing moisture accumulation, and providing cushioning to minimize the risk of ulcers. This article delves deeply into the diabetic socks market, exploring…
Diabetic Food Market
Future Market Insights (FMI) delivers key insights on the global diabetic food market in its latest report titled “Diabetic Food Market: Global Industry Analysis and Opportunity Assessment, 2014 – 2020”. The global diabetic food market is expected to amplify at a CAGR of 5.9% during the forecast period in terms of value due to various factors, regarding which FMI offers fundamental insights in detail in this report.
On the basis of…
Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and…
Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282
Global Diabetic Socks Market: Factors Impacting the Market
The primary factors driving the growth of the global diabetic socks market are increasing…
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be…
